https://www.selleckchem.com/pr....oducts/lanifibranor-
In addition, the device modified local flow patterns, reducing vorticity and better feeding the incorporated branch. This experimental study provides the basis for a better understanding of the mechanism of the MFM device, which allows intra-aneurysmal flow to decrease while preserving incorporated branch flow and reducing the risk of type II endoleak. The experimental system developed for this study was effective in simulating an endovascular procedure and studying the safety and effectiveness of endovascular devices. This